{
  "title": "Generative Large Language Modelâ€”Powered Conversational AI App for Personalized Risk Assessment: Case Study in COVID-19",
  "url": "https://openalex.org/W4407864206",
  "year": 2025,
  "authors": [
    {
      "id": "https://openalex.org/A5093984392",
      "name": "Mohammad Amin Roshani",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2103202294",
      "name": "Xiangyu Zhou",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2136264524",
      "name": "Yao Qiang",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2498739161",
      "name": "Srinivasan Suresh",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2038212053",
      "name": "Steven Hicks",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2262256706",
      "name": "Usha Sethuraman",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2309060557",
      "name": "Dongxiao Zhu",
      "affiliations": []
    }
  ],
  "references": [
    "https://openalex.org/W2904476118",
    "https://openalex.org/W3004643689",
    "https://openalex.org/W2963341956",
    "https://openalex.org/W2937845937",
    "https://openalex.org/W2963716420",
    "https://openalex.org/W3160137267",
    "https://openalex.org/W4327810158",
    "https://openalex.org/W3029340963",
    "https://openalex.org/W4319460874",
    "https://openalex.org/W4319662928",
    "https://openalex.org/W4323350039",
    "https://openalex.org/W4385330606",
    "https://openalex.org/W4380730209",
    "https://openalex.org/W4386120650",
    "https://openalex.org/W4321499561",
    "https://openalex.org/W4390961201",
    "https://openalex.org/W4401042729",
    "https://openalex.org/W4360891289",
    "https://openalex.org/W4406152279",
    "https://openalex.org/W4394782456",
    "https://openalex.org/W4405105409",
    "https://openalex.org/W4384918448",
    "https://openalex.org/W4393300262",
    "https://openalex.org/W2498119267",
    "https://openalex.org/W2137532674",
    "https://openalex.org/W2295598076",
    "https://openalex.org/W3168867926",
    "https://openalex.org/W4376630729",
    "https://openalex.org/W2962862931",
    "https://openalex.org/W4307001389",
    "https://openalex.org/W3205068155",
    "https://openalex.org/W4401753960",
    "https://openalex.org/W4404781857",
    "https://openalex.org/W4388788800",
    "https://openalex.org/W4240861882"
  ],
  "abstract": "Background Large language models (LLMs) have demonstrated powerful capabilities in natural language tasks and are increasingly being integrated into health care for tasks like disease risk assessment. Traditional machine learning methods rely on structured data and coding, limiting their flexibility in dynamic clinical environments. This study presents a novel approach to disease risk assessment using generative LLMs through conversational artificial intelligence (AI), eliminating the need for programming. Objective This study evaluates the use of pretrained generative LLMs, including LLaMA2-7b and Flan-T5-xl, for COVID-19 severity prediction with the goal of enabling a real-time, no-code, risk assessment solution through chatbot-based, question-answering interactions. To contextualize their performance, we compare LLMs with traditional machine learning classifiers, such as logistic regression, extreme gradient boosting (XGBoost), and random forest, which rely on tabular data. Methods We fine-tuned LLMs using few-shot natural language examples from a dataset of 393 pediatric patients, developing a mobile app that integrates these models to provide real-time, no-code, COVID-19 severity risk assessment through clinician-patient interaction. The LLMs were compared with traditional classifiers across different experimental settings, using the area under the curve (AUC) as the primary evaluation metric. Feature importance derived from LLM attention layers was also analyzed to enhance interpretability. Results Generative LLMs demonstrated strong performance in low-data settings. In zero-shot scenarios, the T0-3b-T model achieved an AUC of 0.75, while other LLMs, such as T0pp(8bit)-T and Flan-T5-xl-T, reached 0.67 and 0.69, respectively. At 2-shot settings, logistic regression and random forest achieved an AUC of 0.57, while Flan-T5-xl-T and T0-3b-T obtained 0.69 and 0.65, respectively. By 32-shot settings, Flan-T5-xl-T reached 0.70, similar to logistic regression (0.69) and random forest (0.68), while XGBoost improved to 0.65. These results illustrate the differences in how generative LLMs and traditional models handle the increasing data availability. LLMs perform well in low-data scenarios, whereas traditional models rely more on structured tabular data and labeled training examples. Furthermore, the mobile app provides real-time, COVID-19 severity assessments and personalized insights through attention-based feature importance, adding value to the clinical interpretation of the results. Conclusions Generative LLMs provide a robust alternative to traditional classifiers, particularly in scenarios with limited labeled data. Their ability to handle unstructured inputs and deliver personalized, real-time assessments without coding makes them highly adaptable to clinical settings. This study underscores the potential of LLM-powered conversational artificial intelligence (AI) in health care and encourages further exploration of its use for real-time, disease risk assessment and decision-making support.",
  "full_text": null,
  "topic": "Preprint",
  "concepts": [
    {
      "name": "Preprint",
      "score": 0.9224291443824768
    },
    {
      "name": "Coronavirus disease 2019 (COVID-19)",
      "score": 0.8040043711662292
    },
    {
      "name": "2019-20 coronavirus outbreak",
      "score": 0.5333670973777771
    },
    {
      "name": "Computer science",
      "score": 0.5206100940704346
    },
    {
      "name": "Generative grammar",
      "score": 0.5048037767410278
    },
    {
      "name": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
      "score": 0.4826405644416809
    },
    {
      "name": "Artificial intelligence",
      "score": 0.3669735789299011
    },
    {
      "name": "Virology",
      "score": 0.24485448002815247
    },
    {
      "name": "Medicine",
      "score": 0.24169382452964783
    },
    {
      "name": "World Wide Web",
      "score": 0.19509539008140564
    },
    {
      "name": "Outbreak",
      "score": 0.0
    },
    {
      "name": "Infectious disease (medical specialty)",
      "score": 0.0
    },
    {
      "name": "Disease",
      "score": 0.0
    },
    {
      "name": "Pathology",
      "score": 0.0
    }
  ],
  "institutions": [
    {
      "id": "https://openalex.org/I185443292",
      "name": "Wayne State University",
      "country": "US"
    },
    {
      "id": "https://openalex.org/I177721651",
      "name": "Oakland University",
      "country": "US"
    },
    {
      "id": "https://openalex.org/I4210130600",
      "name": "Children's Hospital of Pittsburgh",
      "country": "US"
    },
    {
      "id": "https://openalex.org/I82783531",
      "name": "Penn State Milton S. Hershey Medical Center",
      "country": "US"
    },
    {
      "id": "https://openalex.org/I4210130818",
      "name": "Children's Hospital of Michigan",
      "country": "US"
    }
  ],
  "cited_by": 5
}